This company has no dividend history.
Based on TTM and annual data · Not a buy/sell signal
This company does not pay dividends
No dividend history found in SEC filings.
Does Emergent BioSolutions (EBS) pay a dividend?
Emergent BioSolutions (EBS) has never paid a dividend. It returns cash through buybacks instead, at roughly a 9.0% buyback yield over the last twelve months. The business does generate free cash flow of $188 million, so the absence of a dividend is a capital-allocation choice rather than an inability to pay. All figures are computed from company filings; this is analysis, not investment advice.
Frequently asked
Does Emergent BioSolutions (EBS) pay a dividend?+
No. Emergent BioSolutions (EBS) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.
How does Emergent BioSolutions return cash to shareholders?+
Through share buybacks rather than dividends. Over the last twelve months Emergent BioSolutions reduced its share count at a rate equivalent to a 9.0% buyback yield. A buyback returns value by shrinking the share count, so each remaining share owns more of the business, but unlike a dividend it pays you nothing in cash and can be stopped at any time without an announcement.
Could Emergent BioSolutions afford to pay a dividend?+
On the numbers, yes. Emergent BioSolutions generated $188 million of free cash flow, which is about $3.67 per share. If it paid out half of that, the dividend would be roughly $1.84 per share, a yield of about 31.1% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Emergent BioSolutions.
SourceDividend analysis computed from the 10-Q filed 26 Oct 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 4 Nov 2026. How this is calculated.
Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.
Peers
Pharmaceutical Preparations · Pick stocks to compare with EBS
Held by ETFs
EBS is in 32 US ETFs. The largest of them, with EBS's weight in each:
Avantis U.S. Small Cap Value ETFAVUV0.08%of the fund
Vanguard Health Care ETFVHT0.00%of the fund
iShares Russell 2000 Value ETFIWN0.03%of the fund
Dimensional U.S. Targeted Value ETFDFAT0.02%of the fund
State Street SPDR S&P Biotech ETFXBI0.11%of the fund
Schwab Fundamental U.S. Small Company ETFFNDA0.03%of the fund
Spot a number that looks wrong? Check it in EBS's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing EBS
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.